Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 95, Issue 1-5, 2005, Pages 129-136

  Brueggemeier, Robert W ^a   Díaz Cruz, Edgar S ^a   Li, Pui Kai ^a   Sugimoto, Yasuro ^a   Lin, Young C ^a   Shapiro, Charles L ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aromatase; Cox 2 inhibitors; Cyclooxygenase 1; Cyclooxygenase 2; NSAIDs; Prostaglandin E2

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; AROMATASE; CELECOXIB; CYCLIC AMP; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; ENZYME INHIBITOR; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SMALL INTERFERING RNA;

AUTOCRINE EFFECT; BIOCHEMISTRY; BIOSYNTHESIS; BREAST CANCER; CANCER CELL CULTURE; CANCER RISK; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION;

AROMATASE; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 23744462619     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.04.013     Document Type: Conference Paper

References (28)

1. American Cancer Society, Facts and Figures, 2004.
2. E.R. Simpson, M.S. Mahendroo, G.D. Means, M.W. Kilgore, M.M. Hinshelwood, S. Graham-Lorence, B. Amarneh, Y. Ito, C.R. Fisher, and M.D. Michael Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr. Rev. 15 1994 342 355
3. V.H.T. James, J.M. McNeill, L.C. Lai, C.J. Newton, H. Braunsberg, M. Ghilchik, and M.J. Reed Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies Steroids 50 1987 269 279
4. W.R. Miller, and J. O'Neill The importance of local synthesis of estrogen within the breast Steroids 50 1987 537 548
5. M.J. Reed, A.M. Owen, L.C. Lai, N.G. Coldham, M.W. Ghilchik, N.A. Shaikh, and V.H.T. James In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxy-androstenedione Int. J. Cancer 44 1989 233 237
6. M.J. Reed The role of aromatase in breast tumors Breast Canc. Res. Treat. 30 1994 7 17
7. S.E. Bulun, T.M. Price, M.S. Mahendroo, J. Aitken, and E.R. Simpson A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcriptase J. Clin. Endocrinol. Metab. 77 1993 1622 1628
8. M. Dowsett, V. Macaulay, J. Gledhill, C. Ryde, J. Nicholls, A. Ashworth, J.A. McKinna, and I.E. Smith Control of aromatase in breast cancer cells and its importance for tumor growth J. Steroid Biochem. Mol. Biol. 44 1993 605 609
9. W.R. Miller, P. Mullen, P. Sourdaine, C. Watson, J.M. Dixon, and J. Telford Regulation of aromatase activity within the breast J. Steroid Biochem. Mol. Biol. 61 1997 193 202
10. M.J. Reed, L. Topping, N.G. Coldham, A. Purohit, M.W. Ghilchik, and V.H.T. James Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors J. Steroid Biochem. Mol. Biol. 44 1993 589 596
11. A.L. Quinn, W.E. Burak Jr., and R.W. Brueggemeier Effects of matrix components on aromatase activity in breast stromal cells in culture J. Steroid Biochem. Mol. Biol. 70 1999 249 256
12. N. Harada, T. Utsumi, and Y. Takagi Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 90 1993 11312 11316
13. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 1996 5739 5742
14. C. Zhou, D. Zhou, J. Esteban, J. Murai, P.K. Siiteri, S. Wilczynski, and S. Chen Aromatase gene expression and its exon I usage in human breast tumors J. Steroid Biochem. Mol. Biol. 59 1996 163 171
15. R. Hughes, P. Timmermans, and M.P. Schrey Regulation of arachidonic acid metabolism, aromatase activity, and growth in human breast cancer cells by interleukin-1β and phorbol ester Int. J. Cancer 67 1996 684 689
16. R.E. Harris, K.K. Namboodiri, and W.B. Farrar Nonsteroidal antiinflammatory drugs and breast cancer risk Epidemiology 7 1996 203 205
17. R.E. Harris, F.M. Robertson, and R.W. Brueggemeier Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer Med. Hypothesis 52 1999 291 292
18. R.W. Brueggemeier, A.L. Quinn, M.L. Parrett, F.S. Joarder, R.E. Harris, and F.M. Robertson Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens Cancer Lett. 140 1999 27 35
19. F.M. Robertson, M.L. Parrett, and F.S. Joarder Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas Cancer Lett. 122 1998 165 175
20. S.A. Khuder, and A.B. Mutgi Breast cancer and NSAID use: a meta-analysis Br. J. Cancer 84 2001 1188 1192
21. P.G. Moorman, J.M. Grubber, R.C. Millikan, and B. Newman Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast Cancer Causes Control 14 2003 915 922
22. C.R. Sharpe, J.P. Collet, M. McNutt, E. Belzile, J.F. Boivin, and J.A. Hanley Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage Br. J. Cancer 83 2000 112 120
23. H. Mori, S. Sugie, W. Rahman, and N. Suzui Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats Cancer Lett. 143 1999 195 198
24. D.L. McCormick, and R.C. Moon Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent Br. J. Cancer 48 1983 859 861
25. N. Kundu, and A.M. Fulton Selective cyclooxygenase COX-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer Cancer Res. 62 2002 2343 2346
26. R.E. Harris, G.A. Alshafie, H. Abou-Issa, and K. Seibert Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor Cancer Res. 60 2000 2101 2103
27. E.S. Diaz-Cruz, C.L. Shapiro, and R.W. Brueggemeier Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells J. Clin. Endocrinol. Metab. 90 2005 2563 2570
28. D.M. Dykxhoorn, C.D. Novina, and P.A. Sharp Killing the messenger: short RNAs that silence gene expression Nature Rev. Mol. Cell Biol. 4 2003 457 467